FDA Approval of Jemperli for Endometrial Cancer Treatment

The FDA has approved a new immunotherapy drug called Jemperli for certain adult patients with endometrial cancer. This is the third FDA approval this year for immunotherapy in endometrial cancer, showing improved outcomes for patients.